STOCK TITAN

MINERVA SURGICAL NEW (UTRS) Stock Price, News & Analysis

UTRS OTC
Published by Stock Titan Data refreshed

What Changed

Price Move History

Daily moves over 5%
5 19 sessions, August 6, 2025 to August 19, 2026
Largest daily move
+900% close of November 4, 2025
1-year change
+0% closing prices, August 6, 2025 to August 19, 2026

Company Description

MINERVA SURGICAL NEW (OTC: UTRS) is classified in the medical devices industry within the Healthcare sector and carries a market capitalization of $89.0.

UTRS has gained 0.0% over the past year. The last closing price was $0.0001.

For FY2022, MINERVA SURGICAL NEW reported revenue of $50.3M with net income of -$34.1M and diluted earnings per share of -$1.18. The company operates at a net profit margin of -67.8%.

This page collects what Stock Titan holds for UTRS, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
-
-
Last updated:
+0%
Performance 1 year

MINERVA SURGICAL NEW (UTRS) closed at $0.0001 on August 19, 2026. Over the past 12 months, the price has gained 0.0%.

See what a $1,000 investment in UTRS would be worth today

UTRS Metrics & Rankings

Price returns through August 19, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

Latest News

MINERVA SURGICAL NEW has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include earnings, management, private placement, conferences. View all UTRS news →

SEC Filings

No SEC filings available for UTRS.

Financial Highlights

MINERVA SURGICAL NEW generated $50.3M in revenue in FY2022, retaining a 54.2% gross margin, operating income reached -$30.9M (-61.4% operating margin), and net income was -$34.1M, reflecting a -67.8% net profit margin. Diluted earnings per share stood at -$1.18. The company generated -$35.6M in operating cash flow. With a current ratio of 2.53, the balance sheet reflects a strong liquidity position.

$50.3M
Revenue (FY2022)
-$34.1M
Net Income (FY2022)
-$35.6M
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Short interest in MINERVA SURGICAL NEW (UTRS) currently stands at 102 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months

Days to cover for MINERVA SURGICAL NEW (UTRS) currently stands at 2.8 days, up 176% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has decreased 99.7% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.

UTRS Company Profile & Sector Positioning

MINERVA SURGICAL NEW (UTRS) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC.

Investors comparing UTRS often look at related companies in the same sector, including THERMOGENESIS HLDGS INC (THMO), FUSE MEDICAL INC (FZMD), TALIS BIOMEDICAL CORP (TLIS), NUGEN MED DEVICES INC (NGMDF), and IR-MED INC (IRME). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate UTRS's relative position within its industry.

Frequently Asked Questions

What is the current stock price of MINERVA SURGICAL NEW (UTRS)?

The current stock price of MINERVA SURGICAL NEW (UTRS) is $0.0001 as of August 19, 2026.

What is the market cap of MINERVA SURGICAL NEW (UTRS)?

The market cap of MINERVA SURGICAL NEW (UTRS) is approximately $89.0. Learn more about what market capitalization means .

What is the revenue of MINERVA SURGICAL NEW (UTRS) stock?

The FY2022 revenue of MINERVA SURGICAL NEW (UTRS) is $50.3M, from its most recent completed fiscal year.

What is the net income of MINERVA SURGICAL NEW (UTRS)?

The FY2022 net income of MINERVA SURGICAL NEW (UTRS) is -$34.1M, from its most recent completed fiscal year.

What is the earnings per share (EPS) of MINERVA SURGICAL NEW (UTRS)?

The diluted earnings per share (EPS) of MINERVA SURGICAL NEW (UTRS) is -$1.18 for FY2022, its most recent completed fiscal year. Learn more about EPS .

What is the operating cash flow of MINERVA SURGICAL NEW (UTRS)?

The operating cash flow of MINERVA SURGICAL NEW (UTRS) is -$35.6M. Learn about cash flow.

What is the profit margin of MINERVA SURGICAL NEW (UTRS)?

The net profit margin of MINERVA SURGICAL NEW (UTRS) is -67.8%. Learn about profit margins.

What is the operating margin of MINERVA SURGICAL NEW (UTRS)?

The operating profit margin of MINERVA SURGICAL NEW (UTRS) is -61.4%. Learn about operating margins.

What is the gross margin of MINERVA SURGICAL NEW (UTRS)?

The gross profit margin of MINERVA SURGICAL NEW (UTRS) is 54.2%. Learn about gross margins.

What is the current ratio of MINERVA SURGICAL NEW (UTRS)?

The current ratio of MINERVA SURGICAL NEW (UTRS) is 2.53, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the gross profit of MINERVA SURGICAL NEW (UTRS)?

The gross profit of MINERVA SURGICAL NEW (UTRS) is $27.2M for FY2022, its most recent completed fiscal year.

What is the operating income of MINERVA SURGICAL NEW (UTRS)?

The operating income of MINERVA SURGICAL NEW (UTRS) is -$30.9M. Learn about operating income.